Nebula is free while in beta — browse the evidence map with no account.Open Nebula →

approval · primary record

BUMETANIDE

FDA · NDA · 2025-09-12

AgencyFDA
Submission typeNDA
Action date2025-09-12
BrandENBUMYST
SponsorCORSTASIS THERAP
RouteNASAL

Provenance

  • Source: openFDA Drugs@FDA
  • Fetched at: 2026-10-28T10:38:32.966Z
  • Licence class: public-domain
  • Verdict: primary-source
  • Entity id: FDA:BUMETANIDE:2025-09-12

This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.

Same entity, elsewhere in the suite